What are biomaterials?

Dental treatments are a matter of trust: our experience and expertise is something you can rely on.
Biomaterials from Geistlich Pharma AG are the most frequently used materials in regenerative dentistry throughout the world.1-7
Over 15 million patients worldwide have been treated with them.8
- Geistlich products are high quality Swiss biomaterials
- They were evaluated in more than 1,400 scientific publications from countries all over the world
- Meticulous selection of raw materials, together with a strictly controlled manufacturing process, allows Geistlich biomaterials to conform to high safety requirements and ensures high tolerability
- These are medical devices in conformance with the applicate market requirements for safety and performance as confirmed by international and national regulatory bodies
References:
- Europe market report suite for dental bone graft substitutes and other biomaterials, iDATA_EUDBGS19_MS, Published in July 2019 by iData Research Inc., 2019
- China market report suite for dental bone graft substitutes and other biomaterials, iDATA_CHDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
- Australia market report suite for dental bone graft substitutes and other biomaterials, iDATA_AUDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
- India market report suite for dental bone graft substitutes and other biomaterials, iDATA_INDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
- South Korea market report suite for dental bone graft substitutes and other biomaterials, iDATA_SKDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
- Japan market report suite for dental bone graft substitutes and other biomaterials, iDATA_JPDBGS18_MS, Published in November 2018 by iData Research Inc., 2018
- US market report suite for dental bone graft substitutes and other biomaterials, iDATA_USDBGS19_MS, Published in January 2019 by iData Research Inc., 2019
- Numbers on Geistlich product use: data on file, Geistlich Pharma AG

Geistlich Pharma AG follows a strict manufacturing process.
Geistlich biomaterials are produced from meticulously selected raw materials. They are subject to rigorous controls and conform to the highest safety requirements.
- Careful selection of raw materials
- Bone or collagen exclusively from monitored establishments
- Highly effective cleaning and purification processes
- Regular inspection of production processes by independent institutions and government authorities
- Meticulous sterilisation of end products
- Sterile pressure chambers for the manufacturing process and packaging
- Individual manual quality control in Switzerland
- Certified quality management system
The information in this website is solely provided for information purposes. Such information is not meant to be a substitute for advice provided by a dentist.